Kenya has kicked off the clinical trial to evaluate the effectiveness and safety of ChAdOx1 nCoV-19, a Covid-19 vaccine candidate. In a statement on Friday, the Kenya Medical Research Institute confirmed that the trial team has vaccinated its first volunteers. Once the vaccine safety is confirmed, a further 360 volunteers will be recruited with possible expansion of the trial to Mombasa county. According to Kemri, the vaccine trial volunteers will be monitored over a period of 12 months to assess their health, any vaccine side-effects and how their bodies develop immunity in response to the vaccine. More than 10,000 volunteers have so far been immunised across the global trial sites and the vaccine found to be well tolerated.

Source: The Star October 30, 2020 12:56 UTC